1st Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$620,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Biosimilars, Patent Reform HR 1260, Patent Reform Act of 2009 S. 515, Patent Reform Act of 2009

LobbyistCovered position, as disclosed
RAYMOND FROST New —
STEPHEN D MCMILLAN —
PETER NORMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1260 (111th), S. 515 (111th)

Medicare/Medicaid MMM

Health Reform, Comparative Effectiveness, Medicare "non-interference," Alzheimer's Awareness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85

LobbyistCovered position, as disclosed
RAYMOND FROST New —
STEPHEN D MCMILLAN —
PETER NORMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.Con.Res. 85 (111th), H.R. 1 (111th), S.Con.Res. 13 (111th)

Health Issues HCR

Health Reform, Comparative Effectiveness, Alzheimer's Awareness H.R. 1, American Recovery and Reinvestment Act of 2009

LobbyistCovered position, as disclosed
RAYMOND FROST New —
STEPHEN D MCMILLAN —
PETER NORMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1 (111th)

Pharmacy PHA

HR 1427, Promoting Innovation and Access to Life-Saving Medicine Act HR 1548, Pathway for Biosimilars Act of 2009 S. 726, Promoting Innovation and Access to Life-Saving Medicine Act

LobbyistCovered position, as disclosed
RAYMOND FROST New —
STEPHEN D MCMILLAN —
PETER NORMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 726 (111th), H.R. 1548 (111th), H.R. 1427 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.